Helping projects
change the future
APPLY NOW

News

TOP 3 most risky and promising areas of biotech

7 February 2018

Primer Capital’s Investment Project Manager Vitaly Kolobov shared his view on some of the things that a “non-profile” investor should keep in mind when investing in biotech.

TOP 3 most risky and promising areas of biotech

Primer Capital’s Investment Project Manager Vitaly Kolobov shared his view on some of the things that a “non-profile” investor should keep in mind when investing in biotech.
 

Why pharmaceutical companies abandon the development of important drugs?

22 January 2018

Yuriy Chirgadze wrote a column about pharmaceutical companies closing their drug development programs that they have been investing in for many years.

Why pharmaceutical companies abandon the development of important drugs?

Yuriy Chirgadze wrote a column about pharmaceutical companies closing their drug development programs that they have been investing in for many years.
 

Primer Capital invests in drug for ischemic stroke

16 January 2018

The total amount of the round, including the grant financing, investments from Primer Capital, other funds and private investors, is EUR 3.9 million.

Primer Capital invests in drug for ischemic stroke

The total amount of the round, including the grant financing, investments from Primer Capital, other funds and private investors, is EUR 3.9 million.
 

How passion for math and biology brought COO Primer Capital to the venture industry

9 January 2018

Elizaveta Rozhdestvenskaya told Firrma how she started in the venture business, whose life example inspires her and what her typical day looks like.

How passion for math and biology brought COO Primer Capital to the venture industry

Elizaveta Rozhdestvenskaya told Firrma how she started in the venture business, whose life example inspires her and what her typical day looks like.
 

FK Laboratoriz successfully completes pre-clinical development of a medication for treatment and prevention of thrombosis

26 December 2017

FK Laboratoriz, a project company in Primer Capital’s portfolio, has completed pre-clinical trials of a new original molecula under the contract with the Russian Ministry of Education and Science as part of Pharma-2020 Federal Target Program.

FK Laboratoriz successfully completes pre-clinical development of a medication for treatment and prevention of thrombosis

FK Laboratoriz, a project company in Primer Capital’s portfolio, has completed pre-clinical trials of a new original molecula under the contract with the Russian Ministry of Education and Science as part of Pharma-2020 Federal Target Program.
 

‘Smart money’ in biotech

22 December 2017

Primer Capital’s Investment Director Olga Tsyuryupa told Forbes how the ‘smart money’ approach minimizes risks of venture capitalists investing in biotech projects.

‘Smart money’ in biotech

Primer Capital’s Investment Director Olga Tsyuryupa told Forbes how the ‘smart money’ approach minimizes risks of venture capitalists investing in biotech projects.
 

Seed Forum 2017

14 December 2017

This international investment forum takes place in 55 countries and unites thousands of funds and business angels all over the world.

Seed Forum 2017

This international investment forum takes place in 55 countries and unites thousands of funds and business angels all over the world.
 

Young Starts in Russian VC & PE

8 December 2017

Nadezhda Kartashova, a project manager in Primer Capital, was ranked second among finalists of the “Young Stars in Russian VC & PE” contest.

Young Starts in Russian VC & PE

Nadezhda Kartashova, a project manager in Primer Capital, was ranked second among finalists of the “Young Stars in Russian VC & PE” contest.
 

Venture Investments Course by the Skolkovo Moscow School of Management

5 December 2017

On December 3, 2017, I have attended the Venture Investments Course. During this event, I presented a speech about structuring of venture transactions and risk minimization methods for investors.

Venture Investments Course by the Skolkovo Moscow School of Management

On December 3, 2017, I have attended the Venture Investments Course. During this event, I presented a speech about structuring of venture transactions and risk minimization methods for investors.
 

Eurika! Concept

28 November 2017

Primer Capital was invited to join a panel of judges at the ‘New Approaches to Drug Development’ sub-section on November 23, 2017 as part of annual reporting session for winners of the ‘Eureka! Concept’ competition.

Eurika! Concept

Primer Capital was invited to join a panel of judges at the ‘New Approaches to Drug Development’ sub-section on November 23, 2017 as part of annual reporting session for winners of the ‘Eureka! Concept’ competition.

Записи 41 - 50 of 56
First | Prev. | 2 3 4 5 6 | Next | Last